{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:14:53Z","timestamp":1790172893563,"version":"4.1.0"},"reference-count":25,"publisher":"The Endocrine Society","issue":"12","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>US papillary thyroid carcinoma (PTC) incidence recently declined for the first time in decades, for reasons that remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aims to evaluate PTC incidence trends, including by histologic subtype and size, and noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>This descriptive study uses US Surveillance, Epidemiology, and End Results\u201318 cancer registry data (2000-2017).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>Participants included individuals diagnosed with PTC (2000-2017) or NIFTP (2016-2017).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 2000 to 2015, PTC incidence increased an average 7.3% per year, (95% CI, 6.9% to 7.8%) during 2000 to 2009, and 3.7% per year (95% CI, 0.2% to 7.3%) during 2009 to 2012, before stabilizing in 2012 to 2015 (annual percentage change [APC]\u2005=\u20051.4% per year, 95% CI, \u20131.8% to 4.7%) and declining in 2015 to 2017 (APC\u2005=\u2005\u20134.6% per year, 95% CI, \u20137.6% to \u20131.4%). The recent declines were observed for all sizes of PTC at diagnosis. Incidence of follicular variant of PTC (FVPTC) sharply declined in 2015 to 2017, overall (APC\u2005=\u2005\u201321.1% per year; 95% CI, \u201326.5% to \u201315.2%) and for all tumor sizes. Observed increases in encapsulated papillary carcinoma (classical PTC subtype) and NIFTP each accounted for 10% of the decline in FVPTC. Classical PTC incidence continuously increased (2000-2009, APC\u2005=\u20058.7% per year, 95% CI, 8.1% to 9.4%; 2009-2017, APC\u2005=\u20051.0% per year, 95% CI, 0.4% to 1.5%), overall and for all sizes except smaller than 1 cm, as did incidence of other PTC variants combined (2000-2017, APC\u2005=\u20055.9% per year, 95% CI, 4.0% to 7.9%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The reasons underlying PTC incidence trends were multifactorial. Sharp declines in FVPTC incidence during 2015 to 2017 coincided with clinical practice and diagnostic coding changes, including reclassification of noninvasive encapsulated FVPTC from a malignant to in situ neoplasm (NIFTP). Observed increases in NIFTP accounted for 10% of the decline in FVPTC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa690","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T01:15:09Z","timestamp":1601255709000},"page":"e4823-e4830","source":"Crossref","is-referenced-by-count":41,"title":["Influence of Nomenclature Changes on Trends in Papillary Thyroid Cancer Incidence in the United States, 2000 to 2017"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6416-4432","authenticated-orcid":false,"given":"Cari M","family":"Kitahara","sequence":"first","affiliation":[{"name":"Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Sosa","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8390-6091","authenticated-orcid":false,"given":"Meredith S","family":"Shiels","sequence":"additional","affiliation":[{"name":"Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,9,28]]},"reference":[{"issue":"13","key":"2021122106324203900_CIT0001","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in thyroid cancer incidence and mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA."},{"issue":"8","key":"2021122106324203900_CIT0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1089\/thy.2020.0321","article-title":"Reversal in thyroid cancer incidence trends in the United States, 2000-2017","volume":"30","author":"Lee","year":"2020","journal-title":"Thyroid."},{"issue":"8","key":"2021122106324203900_CIT0003","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1089\/thy.2019.0415","article-title":"Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations","volume":"30","author":"Pereira","year":"2020","journal-title":"Thyroid."},{"issue":"5","key":"2021122106324203900_CIT0004","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaoncol.2019.6851","article-title":"Incidence and mortality risk spectrum across aggressive variants of papillary thyroid carcinoma","volume":"6","author":"Ho","year":"2020","journal-title":"JAMA Oncol."},{"issue":"11","key":"2021122106324203900_CIT0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid."},{"issue":"1","key":"2021122106324203900_CIT0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid."},{"issue":"18","key":"2021122106324203900_CIT0007","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2017.4011","article-title":"Screening for thyroid cancer: US Preventive Services Task Force recommendation statement","volume":"317","author":"Bibbins-Domingo","year":"2017","journal-title":"JAMA."},{"issue":"24","key":"2021122106324203900_CIT0008","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1001\/jama.2019.18528","article-title":"Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016","volume":"322","author":"Powers","year":"2019","journal-title":"JAMA."},{"issue":"4","key":"2021122106324203900_CIT0009","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.2016.0628","article-title":"American Thyroid Association guidelines on the management of thyroid nodules and differentiated thyroid cancer task force review and recommendation on the proposed renaming of encapsulated follicular variant papillary thyroid carcinoma without invasion to noninvasive follicular thyroid neoplasm with papillary-like nuclear features","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid."},{"issue":"8","key":"2021122106324203900_CIT0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol."},{"key":"2021122106324203900_CIT0011","author":"North American Association of Central Cancer Registries (NAACCR)"},{"key":"2021122106324203900_CIT0012","volume-title":"WHO Classification of Tumours of Endocrine Organs.","author":"Lloyd","year":"2017","edition":"4"},{"issue":"8","key":"2021122106324203900_CIT0013","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jamaoncol.2018.1446","article-title":"Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features","volume":"4","author":"Nikiforov","year":"2018","journal-title":"JAMA Oncol."},{"key":"2021122106324203900_CIT0014","author":"Kitahara"},{"issue":"2","key":"2021122106324203900_CIT0015","doi-asserted-by":"crossref","first-page":"E276","DOI":"10.1210\/jc.2013-2503","article-title":"The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations","volume":"99","author":"Jung","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021122106324203900_CIT0016","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00268-020-05521-2","article-title":"BRAFV600E mutation is associated with an increased risk of papillary thyroid cancer recurrence","volume":"44","author":"Enumah","year":"2020","journal-title":"World J Surg."},{"issue":"14","key":"2021122106324203900_CIT0017","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"JAMA."},{"issue":"8","key":"2021122106324203900_CIT0018","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med."},{"issue":"8","key":"2021122106324203900_CIT0019","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jnci\/djz202","article-title":"Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995-2015)","volume":"112","author":"Kitahara","year":"2020","journal-title":"J Natl Cancer Inst."},{"key":"2021122106324203900_CIT0020","article-title":"Obesity is associated with BRAFV600E-mutated thyroid cancer. [Published online ahead of print May 4, 2020.]","author":"Rahman","journal-title":"Thyroid."},{"issue":"6 Suppl 3","key":"2021122106324203900_CIT0021","doi-asserted-by":"crossref","first-page":"S683","DOI":"10.1245\/s10434-015-4765-z","article-title":"Association between obesity and BRAFV600E mutation status in patients with papillary thyroid cancer","volume":"22","author":"Lee","year":"2015","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"2021122106324203900_CIT0022","doi-asserted-by":"crossref","first-page":"8383","DOI":"10.1007\/s13277-015-4718-y","article-title":"Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer","volume":"37","author":"Shi","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"2021122106324203900_CIT0023","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/thy.2015.0319","article-title":"Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies","volume":"26","author":"Kitahara","year":"2016","journal-title":"Thyroid."},{"issue":"18","key":"2021122106324203900_CIT0024","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2017.4068","article-title":"How to look for thyroid cancer","volume":"317","author":"Cappola","year":"2017","journal-title":"JAMA."},{"issue":"9","key":"2021122106324203900_CIT0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/modpathol.2010.112","article-title":"Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns","volume":"23","author":"Rivera","year":"2010","journal-title":"Mod Pathol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa690\/33797483\/dgaa690.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/12\/e4823\/41829482\/dgaa690.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/12\/e4823\/41829482\/dgaa690.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T01:35:45Z","timestamp":1640050545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/12\/e4823\/5912267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,28]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,9,28]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa690","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,28]]}}}